ImmunoPrecise Antibodies Ltd. (IPA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ImmunoPrecise Antibodies ...

    NASDAQ: IPA · Real-Time Price · USD
    1.77
    0.02 (1.14%)
    At close: Oct 01, 2025, 3:59 PM
    1.71
    -3.39%
    Pre-market: Oct 01, 2025, 09:17 AM EDT

    ImmunoPrecise Antibodies Income Statement

    Financials in CAD. Fiscal year is May - April.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Apr 30, 2025 Apr 30, 2024 Apr 30, 2023 Apr 30, 2022 Apr 30, 2021
    Revenue
    		 24.52M 24.52M 20.66M 19.36M 17.91M
    Cost of Revenue
    		 10.97M 12.46M 9.1M 8.38M 6.37M
    Gross Profit
    		 13.55M 12.05M 11.56M 10.98M 11.54M
    Operating Income
    		 -12.2M -13.76M -25.61M -15.78M -4.18M
    Interest Income
    		 n/a 23K 122K 279K 282K
    Pretax Income
    		 -34.27M -28.7M -27.75M -15.85M -6M
    Net Income
    		 -30.23M -27.18M -26.56M -16.71M -7.34M
    Selling & General & Admin
    		 19.03M 19.14M 18.99M 17.71M 13.34M
    Research & Development
    		 4.94M 4.06M 14.11M 6.69M 1.97M
    Other Expenses
    		 1.77M 2.62M 4.08M 1.94M 475K
    Operating Expenses
    		 25.74M 25.82M 37.17M 27.66M 15.71M
    Interest Expense
    		 293K 19K 30K 85K 863K
    Selling & Marketing Expenses
    		 4.3M 3.54M 3.61M 740K 691K
    Cost & Expenses
    		 36.72M 38.28M 46.28M 35.53M 22.09M
    Income Tax Expense
    		 -4.03M -1.53M -1.19M 861K 1.34M
    Shares Outstanding (Basic)
    		 33.38M 25.64M 24.9M 19.69M 16.47M
    Shares Outstanding (Diluted)
    		 33.38M 25.64M 24.9M 19.69M 16.47M
    EPS (Basic)
    		 -0.91 -1.06 -1.07 -0.85 -0.45
    EPS (Diluted)
    		 -0.91 -1.06 -1.07 -0.85 -0.45
    EBITDA
    		 -28.86M -22.95M -21.04M -11.99M -1.42M
    EBIT
    		 -33.97M -28.68M -27.72M -15.76M -5.13M
    Depreciation & Amortization
    		 5.12M 5.74M 6.68M 3.77M 3.71M

    Add to Watchlist